According to the newly published study, “Biopsy Devices Market Size, Share & Forecast 2023–2031,” by The Insight Partners, the global biopsy devices market is expected to grow from USD 2.83 billion in 2023 to USD 4.59 billion by 2031, registering a compound annual growth rate (CAGR) of 6.20% over the forecast period.

This growth is primarily driven by:

  • Rising incidence of cancer globally, increasing demand for diagnostic procedures
  • Greater adoption of minimally invasive biopsy techniques due to lower patient risk and faster recovery
  • Technological advances integrating real‑time imaging (CT, ultrasound, MRI) with biopsy devices for precision targeting
  • Government and institutional efforts to improve early detection infrastructure in developed and emerging markets

Market Segmentation & Highlights

By Product Type

  • Needle‑Based Biopsy Devices (including core needles, aspiration needles, vacuum‑assisted systems) held the largest share in 2023.
  • Other categories include Localization Wires, Procedure Trays, and various accessory kits.

By Technology / Guidance Modality

  • Ultrasound‑Guided Biopsy was the dominant technology segment in 2023.
  • However, CT‑guided biopsy is forecast to grow at the highest rate during 2023–2031.
  • Other supported modalities are stereotactic, MRI guidance, and hybrid techniques.

By Application (Anatomical Use)

  • Breast Biopsy remains the largest application segment, driven by widespread screening and high awareness.
  • Lung, Kidney, Liver biopsy segments are expected to show above‑average growth over the forecast period.
  • Other applications include prostate, gastrointestinal, skin, and bone marrow biopsies.

Geographical Outlook

  • North America continues to dominate the market in terms of revenue share, due to high adoption of advanced diagnostic tools and strong healthcare infrastructure.
  • Asia-Pacific and Latin America / Middle East & Africa are poised for faster growth owing to rising healthcare investment, increasing cancer burden, and improving access to diagnostic technologies.

Competitive Landscape & Key Players

The report identifies the leading players in the biopsy devices industry and highlights recent strategic advances:

Prominent Companies
Some of the major firms operating in the global biopsy devices market include:

  • BD (Becton, Dickinson & Co.)
  • Hologic, Inc.
  • Medtronic plc
  • Cook Medical LLC
  • Fujifilm Corporation
  • Bio‑Rad Laboratories
  • Cardinal Health, Inc.
  • Danaher Corporation / Mammotome (especially in breast biopsy innovation)

Recent Developments & Innovations

  • Danaher / Mammotome launched the Mammotome Revolve EX Dual Vacuum-Assisted Breast Biopsy System, which targets benign lesion excision with speed and minimally invasive approach.
  • TransMed7 achieved a “First in Human” clinical case for its Heron XPS soft tissue, vacuum‑assisted biopsy device in the product’s commercial form.
  • Innovations in real‑time imaging fusion, AI guidance, and smarter needle designs are emerging as differentiators.

Market Drivers, Challenges & Opportunities

Key Drivers

  • Increasing global cancer burden demanding accurate diagnostics
  • Preference for minimally invasive biopsy approaches due to less trauma, faster recovery, and lower risk
  • Technological advances (imaging integration, navigation, AI) enhancing biopsy precision
  • Policy initiatives and funding for early disease detection, especially in emerging economies

Key Challenges / Restraints

  • High cost of advanced biopsy systems and imaging integration
  • Regulatory hurdles and safety validation required for invasive devices
  • Competition from less invasive diagnostics (e.g., liquid biopsy)
  • Uneven reimbursement policies across geographies

Opportunities

  • Expansion in under‑penetrated emerging markets
  • Integration with digital health, AI & telemedicine
  • Development of next‑generation smart biopsy devices
  • Collaboration with pathology/genomic diagnostics for end‑to‑end solutions

Get Sample PDF- https://www.theinsightpartners.com/sample/TIPHE100001402/

About The Insight Partners

The Insight Partners is a global market research and advisory firm delivering actionable insights across a wide range of industries, with specialization in life sciences and healthcare technologies. Its reports provide in-depth analyses, market sizing, trends, forecasts, and strategic recommendations to help companies, investors, and institutions make data‑driven decisions.

Contact Information
The Insight Partners
Phone: +1‑646‑491‑9876
Email: [email protected]